Pleiotropic effects of PCSK9-inhibition on hemostasis: Anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression.
- Resource Type
- Article
- Source
Thrombosis Research . May2022, Vol. 213, p170-172. 3p.- Subject
- *
HEMOSTASIS
*STATINS (Cardiovascular agents) - Language
- ISSN
- 0049-3848